Bayer’s MRI Contrast Agent Gets FDA Approval

in cardiology •  6 years ago 

Bayer’s Gadavist MRI Contrast Agent Gadavist (gadobutrol) has been approved by FDA for coronary artery disease (CAD). The agency has previously greenlit the gadobutrol injection for use in MRI of the central nervous system and breasts.

https://blog.genexi.ru/news/Bayers-MRIfda-1025x559.jpg-Contrast-Agent-Gets-FDA-Approval-en

cardiology therapy medicine heart fda
6 years ago by

Downvoting a post can decrease pending rewards and make it less visible. Common reasons:

  • Disagreement on rewards
  • Fraud or plagiarism
  • Hate speech or trolling
  • Miscategorized content or spam

Submit
$0.00
    1 vote
    0
    Authors get paid when people like you upvote their post.
    If you enjoyed what you read here, create your account today and start earning FREE STEEM!